Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Taiyo Holdings Co., Ltd. ( (JP:4626) ) just unveiled an announcement.
Taiyo Holdings has announced a set of senior personnel changes across its pharmaceutical and digital operations, resolved at a board meeting on February 4, 2026 and scheduled to take effect on April 1, 2026 following any necessary subsidiary procedures. The reshuffle primarily affects roles at Taiyo Pharma, funlead corp., and Taiyo Pharma Tech, and involves reallocation of responsibilities among senior corporate executive officers, including positions such as Chief Digital Officer and executive oversight of the information systems department, signaling an effort to strengthen management structure and coordination across its pharma and digital businesses within the group.
The most recent analyst rating on (JP:4626) stock is a Buy with a Yen5578.00 price target. To see the full list of analyst forecasts on Taiyo Holdings Co., Ltd. stock, see the JP:4626 Stock Forecast page.
More about Taiyo Holdings Co., Ltd.
Taiyo Holdings Co., Ltd. is a Japanese company listed on the Prime Market of the Tokyo Stock Exchange under code 4626, operating through group subsidiaries such as Taiyo Pharma Co., Ltd., funlead corp., and Taiyo Pharma Tech Co., Ltd., with a business portfolio that includes medical and pharmaceutical operations and digital-related functions within the group.
Average Trading Volume: 330,481
Technical Sentiment Signal: Buy
Current Market Cap: Yen576.8B
For a thorough assessment of 4626 stock, go to TipRanks’ Stock Analysis page.